HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Comparison of molecular markers of hypoxia and imaging with (60)Cu-ATSM in cancer of the uterine cervix.

AbstractPURPOSE:
To determine if hypoxia-related molecular markers are associated with (60)Cu labeled diacetyl-bis (N4 -methylthiosemicarbazone); ((60)Cu-ATSM) imaging of tumor hypoxia in cervical cancer.
PROCEDURES:
Fifteen patients were enrolled in a prospective study and underwent evaluation of tumor hypoxia with positron emission tomography (PET) using (60)Cu-ATSM. (60)Cu-ATSM-PET imaging was compared with the expression of tissue molecular markers, which included vascular endothelial growth factor (VEGF), cyclo-oxygenase-2 (COX-2), epidermal growth factor receptor (EGFR), carbonic anyhdrase IX (CA-9), and apoptotic index.
RESULTS:
Six patients had hypoxic tumors determined by (60)Cu-ATSM, and nine had non-hypoxic tumors. The 4-year overall survival estimates were 75% for patients with non-hypoxic tumors and 33% for those with hypoxic tumors (p = 0.04). Overexpression of VEGF (p = 0.13), EGFR (p = 0.05), CA-9 (p = 0.02), COX-2 (p = 0.08), and the presence of apoptosis (p = 0.005) occurred in patients with hypoxic tumors. Cox proportional hazards modeling demonstrated hypoxia as determined by (60)Cu-ATSM to be a significant independent predictor of tumor recurrence (p = 0.0287).
CONCLUSIONS:
(60)Cu-ATSM hypoxia was correlated with overexpression of VEGF, EGFR, COX-2, CA-9, an increase in apoptosis, and a poor outcome.
AuthorsPerry W Grigsby, Robert S Malyapa, Ryuji Higashikubo, Julie K Schwarz, Michael J Welch, Phyllis C Huettner, Farrokh Dehdashti
JournalMolecular imaging and biology (Mol Imaging Biol) 2007 Sep-Oct Vol. 9 Issue 5 Pg. 278-83 ISSN: 1536-1632 [Print] United States
PMID17431727 (Publication Type: Comparative Study, Journal Article, Research Support, N.I.H., Extramural, Research Support, U.S. Gov't, Non-P.H.S.)
Chemical References
  • Biomarkers
  • Biomarkers, Tumor
  • Coordination Complexes
  • Copper Radioisotopes
  • Organometallic Compounds
  • Radiopharmaceuticals
  • Thiosemicarbazones
  • VEGFA protein, human
  • Vascular Endothelial Growth Factor A
  • copper (II) diacetyl-di(N(4)-methylthiosemicarbazone)
  • Cyclooxygenase 2
  • PTGS2 protein, human
  • ErbB Receptors
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Biomarkers (metabolism)
  • Biomarkers, Tumor (metabolism)
  • Coordination Complexes
  • Copper Radioisotopes
  • Cyclooxygenase 2 (metabolism)
  • ErbB Receptors (metabolism)
  • Female
  • Humans
  • Hypoxia (diagnostic imaging, metabolism)
  • Middle Aged
  • Neovascularization, Pathologic
  • Organometallic Compounds
  • Pilot Projects
  • Prospective Studies
  • Radionuclide Imaging
  • Radiopharmaceuticals
  • Thiosemicarbazones
  • Uterine Cervical Neoplasms (blood supply, diagnostic imaging, metabolism)
  • Vascular Endothelial Growth Factor A (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: